Diminished ovarian reserve
Diminished ovarian reserve describes a lower quantity of remaining oocytes or a lower expected response to ovarian stimulation than would be expected in context. It is not the same as infertility, poor egg quality or premature ovarian insufficiency.
At a glance
Quick facts
- What it reflects
- Oocyte quantity / expected ovarian response
- Common tests
- AMH and antral follicle count
- Most important context
- Age and clinical history
- Does not prove
- Inability to conceive naturally
- Not the same as
- Premature ovarian insufficiency
- Treatment role
- Planning and counselling for fertility care
Dr. Farida Sani
Fertility Physician · Clearview Hospital and Fertility
Reviewed for clinical accuracy, fertility context and patient-facing clarity.
Names & terminology
How this entity may be named or searched
- Ovarian reserve
- The remaining quantity of oocytes and the ovary’s expected response to stimulation.
- AMH
- Anti-Müllerian hormone, a blood marker used to estimate ovarian response.
- AFC
- Antral follicle count, an ultrasound count of small follicles early in the cycle.
- Poor ovarian response
- A lower-than-expected response to ovarian stimulation; definitions vary by context and protocol.
Structured entity profile
Clinical profile
Overview
Ovarian reserve refers mainly to the quantity of remaining oocytes and the likely response of the ovaries to stimulation. ASRM describes diminished ovarian reserve as reduced reproductive potential related to oocyte number and notes that women can have diminished reserve while still having regular menstrual cycles. [1]
The concept is frequently misunderstood as a direct measure of “egg quality” or as a yes/no fertility test. Female age remains a major predictor of fecundity, while AMH and antral follicle count are most useful for anticipating ovarian response during fertility treatment. NICE specifically advises against using AMH as a predictor of spontaneous clinical pregnancy. [2] [3]
Symptoms and warning signs
Diminished ovarian reserve usually has no specific symptoms. Many people continue to have regular periods and only learn about a lower reserve estimate during fertility assessment or before ovarian stimulation. Changes in cycle length can occur with advancing reproductive age, but symptoms alone cannot establish ovarian reserve. [1] [3]
SYMPTOM MATRIX
Diminished reserve is usually identified through fertility assessment
A low reserve marker is most useful when interpreted together with age, history and treatment goals.
- Regular menstrual cycles may continue
- Low AMH or low antral follicle count
- Concern about response to ovarian stimulation
- Difficulty conceiving may or may not be present
- Increasing reproductive age
- Previous ovarian surgery
- Chemotherapy or pelvic radiation
- Endometriosis or ovarian pathology
- Family history of early ovarian insufficiency
- Amenorrhoea or marked cycle irregularity before age 40
- Symptoms of estrogen deficiency
- Very abnormal gonadotrophins with menstrual disturbance
- Known gonadotoxic exposure with fertility plans
Marked menstrual disturbance before age 40 raises the question of premature ovarian insufficiency rather than diminished reserve alone.
Diagnosis
AMH and antral follicle count are commonly used to estimate ovarian response. NICE 2026 recommends using AMH or AFC to inform clinical decision-making and counselling about likely ovarian response and live-birth prospects following assisted conception, while advising against AMH as a predictor of spontaneous conception. [2]
ASRM similarly emphasizes that ovarian reserve testing should augment, not replace, counselling based on age and diagnosis. A low result does not necessarily mean that natural conception is impossible, and a reassuring result does not cancel the effect of age on oocyte quality. [1]
Diagnostic pathway
Interpret reserve tests in context
The result matters most when it answers a practical fertility-treatment question.
Fertility assessment is usually most useful when relevant male and female factors are evaluated in parallel.
What a low AMH result actually means
A low AMH often predicts fewer oocytes retrieved during ovarian stimulation, but it does not by itself prove infertility. Conversely, a high AMH does not guarantee a future pregnancy. The clinically useful question is usually how the ovaries are expected to respond to treatment in the context of age and diagnosis. [1] [2]
Female age remains important when interpreting ovarian reserve because it also helps predict likely response and treatment outcome; reserve tests should not be read in isolation.
Treatment and management
There is no established treatment that restores the depleted follicle pool. Management therefore focuses on reproductive planning: whether to continue trying naturally for a defined period, move sooner to assisted reproduction, adjust stimulation strategy, or discuss alternative family-building options when appropriate. [1] [2]
During IVF, a low predicted response can affect medication planning and expectations about oocyte yield, but treatment decisions should avoid making absolute predictions from one laboratory value. Repeated treatment response can also provide clinically useful information. [1]
Treatment & care hub
Use ovarian reserve to plan, not to label
The value of reserve testing is in setting realistic expectations and choosing timing and treatment strategy.
Put the result beside age and diagnosis
Reserve markers should never be interpreted as a stand-alone prediction of natural fertility.
Anticipate ovarian response
AMH and AFC can help estimate likely oocyte yield and inform stimulation planning.
Avoid unnecessary delay when prognosis is changing
Age, prior surgery and fertility history can affect how quickly treatment is considered.
Discuss the full range of reproductive options
Treatment choices depend on goals, expected response, partner factors and previous outcomes.
Treatment is individualized according to diagnosis, age, reproductive goals and clinical context.
Diminished ovarian reserve versus premature ovarian insufficiency
Diminished ovarian reserve can occur with regular cycles and refers mainly to oocyte quantity or response. Premature ovarian insufficiency is a distinct clinical condition involving loss of ovarian function before age 40, typically with irregular or absent cycles and biochemical evidence of ovarian insufficiency. [1] [4]
Evidence snapshot
Ovarian reserve tests answer a treatment-planning question
Current guidance does not support using AMH as a stand-alone test of spontaneous fertility.
Common questions
Frequently asked questions
No. Low AMH is mainly a marker of ovarian reserve and expected response to stimulation, not a reliable stand-alone predictor of spontaneous pregnancy.
Ovarian reserve tests estimate quantity or response. Egg quality, including chromosomal competence, is strongly related to age and is not directly measured by AMH.
Yes. Regular cycles can continue even when ovarian reserve markers are lower than expected.
No. POI involves loss of ovarian function before age 40 with menstrual disturbance and biochemical confirmation; diminished reserve can exist with ongoing ovulation.
There is no established treatment that replenishes the follicle pool; care focuses on timing, realistic counselling and fertility-treatment strategy.
Sources
- ASRM — Fertility evaluation of infertile women: a committee opinion, 2021
- NICE — Fertility problems: assessment and treatment (NG257) - investigation, 2026
- WHO — Guideline for the prevention, diagnosis and treatment of infertility, 2025
- ESHRE / ASRM / IMS — International guideline on premature ovarian insufficiency, 2024
This article is based on trusted medical sources and has undergone clinician review. It is not a substitute for personalized medical advice.
Absent periods at a young age point more toward premature ovarian insufficiency than diminished ovarian reserve alone and should prompt a different diagnostic assessment.